These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1825248)

  • 1. Mixed lymphocyte reaction-induced release of soluble IL-2 receptor.
    Degiannis D; Czarnecki M; Hornung N; Raskova J; Raska K
    Transplantation; 1991 Feb; 51(2):518-23. PubMed ID: 1825248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-2 responsiveness of lectin-induced lymphoblasts: soluble IL-2 receptor release and differential in vitro effects of immunosuppressants.
    Hornung N; Raskova J; Raska K; Degiannis D
    Int J Immunopharmacol; 1992 Jul; 14(5):753-60. PubMed ID: 1512072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of interleukin 2 on the immunosuppressive action of cyclosporine.
    Hess AD
    Transplantation; 1985 Jan; 39(1):62-8. PubMed ID: 3155579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine A and prednisolone inhibit lectin- and alloantigen-induced release of sCD8: correlation with proliferative responses.
    Kim HS; Degiannis D; Raskova J; Raska K
    Clin Immunol Immunopathol; 1991 Jul; 60(1):27-39. PubMed ID: 1904329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-2 regulation of soluble IL-2 receptor levels following thermal injury.
    Teodorczyk-Injeyan JA; Sparkes BG; Lalani S; Peters WJ; Mills GB
    Clin Exp Immunol; 1992 Oct; 90(1):36-42. PubMed ID: 1382903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of FK-506 and low-concentration ciclosporin on human lymphocyte activation antigen expression and blastogenesis: a flow cytometric analysis.
    Woo J; Sewell HF; Thomson AW
    Scand J Immunol; 1990 Mar; 31(3):297-304. PubMed ID: 1690915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vitro effect on T cell function of soluble IL-2Ralpha from advanced ovarian cancer ascites.
    Elg SA; Hill RB; Heldman L; Ramakrishnan S
    Gynecol Oncol; 1997 Jul; 66(1):133-7. PubMed ID: 9234933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin inhibits the in vitro release of soluble interleukin-2 receptor by activated peripheral blood mononuclear cells (PBMC) independently of the mode of activation.
    Degiannis D; Hornung N
    Int J Immunopharmacol; 1995 Jul; 17(7):593-6. PubMed ID: 8586487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of sIL-2R alpha from and activation of native human peripheral blood mononuclear cells by recombinant IL-15.
    Treiber-Held S; Stewart DM; Barraclough HA; Kurman CC; Nelson DL
    Clin Immunol Immunopathol; 1996 Jul; 80(1):67-75. PubMed ID: 8674241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of precytotoxic T cells in cyclosporine-suppressed mixed lymphocyte reactions.
    Hooton JW; Miller CL; Helgason CD; Bleackley RC; Gillis S; Paetkau V
    J Immunol; 1990 Feb; 144(3):816-23. PubMed ID: 2136900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble interleukin 2 receptors abrogate IL-2 induced activation of peripheral mononuclear cells.
    Zorn U; Dallmann I; Grosse J; Kirchner H; Poliwoda H; Atzpodien J
    Cytokine; 1994 Jul; 6(4):358-64. PubMed ID: 7948742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-CD3 antibody-induced expression of both p55 and p75 chains of the high affinity interleukin-2 receptor on human T lymphocytes is inhibited by cyclosporin A.
    Foxwell BM; Simon J; Herrero JJ; Taylor D; Woerly G; Cantrell D; Ryffel B
    Immunology; 1990 Jan; 69(1):104-9. PubMed ID: 2312149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A soluble 'anchorminus' interleukin 2 receptor suppresses in vitro interleukin 2-mediated immune responses.
    Kondo N; Kondo S; Shimizu A; Honjo T; Hamuro J
    Immunol Lett; 1988 Dec; 19(4):299-307. PubMed ID: 2977379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of anti-interleukin-2 receptor antibody and cyclosporin A on human T cell proliferation in primary mixed lymphocyte reaction.
    Oiwa K; Sakagami K; Orita K
    Hiroshima J Med Sci; 1989 Mar; 38(1):1-6. PubMed ID: 2526799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of immunosuppressive effects of cyclosporin A by 1 alpha,25-dihydroxyvitamin D3.
    Gupta S; Fass D; Shimizu M; Vayuvegula B
    Cell Immunol; 1989 Jul; 121(2):290-7. PubMed ID: 2786759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cyclosporin A on human lymphocyte responses in vitro. III. CsA inhibits the production of T lymphocyte growth factors in secondary mixed lymphocyte responses but does not inhibit the response of primed lymphocytes to TCGF.
    Hess AD; Tutschka PJ; Santos GW
    J Immunol; 1982 Jan; 128(1):355-9. PubMed ID: 6459374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporin A mediated immunosuppression in vitro: effect on high affinity interleukin-2 receptor expression and -turnover.
    Povlsen JV; Møller BK; Christiansen BS; Petersen CM
    Tissue Antigens; 1989 Jan; 33(1):4-14. PubMed ID: 2785298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-2 receptor gene expression in kidney transplant recipients treated with cyclosporin A.
    Yoshimura N; Oka T; Amagai T; Horii Y; Imanishi J
    Clin Exp Immunol; 1991 Aug; 85(2):326-30. PubMed ID: 1864013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. I. Inhibition of expression of alloantigen-activated suppressor cells, as well as induction of alloreactivity.
    Yoshimura N; Matsui S; Hamashima T; Oka T
    Transplantation; 1989 Feb; 47(2):351-6. PubMed ID: 2465592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Soluble interleukin 2 receptor (sIL-2R) in patients with esophageal carcinoma].
    Duan ZF
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):17-9. PubMed ID: 8334935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.